AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
GROWTH PROMOTION BY HOMOCYSTEINE BUT NOT BY HOMOCYSTEIC ACID - A ROLEFOR EXCESSIVE GROWTH IN HOMOCYSTINURIA OR PROLIFERATION IN HYPERHOMOCYSTEINEMIA
Authors: FRITZERSZEKERES M BLOM HJ BOERS GHJ SZEKERES T LUBEC B
Citation: M. Fritzerszekeres et al., GROWTH PROMOTION BY HOMOCYSTEINE BUT NOT BY HOMOCYSTEIC ACID - A ROLEFOR EXCESSIVE GROWTH IN HOMOCYSTINURIA OR PROLIFERATION IN HYPERHOMOCYSTEINEMIA, Biochimica et biophysica acta. Molecular basis of disease, 1407(1), 1998, pp. 1-6
STAUROSPORINE ENHANCED BENZAMIDE RIBOSIDE-INDUCED APOPTOSIS IN HUMAN MULTIDRUG-RESISTANT PROMYELOCYTIC LEUKEMIA-CELLS (HL-60 VCR) IN-VITRO/
Authors: HUNAKOVA L DURAJ J ROMANOVA D NOVOTNY L SEDLAK J KELLEY MR SZEKERES T JAYARAM HN CHORVATH B
Citation: L. Hunakova et al., STAUROSPORINE ENHANCED BENZAMIDE RIBOSIDE-INDUCED APOPTOSIS IN HUMAN MULTIDRUG-RESISTANT PROMYELOCYTIC LEUKEMIA-CELLS (HL-60 VCR) IN-VITRO/, Neoplasma, 45(4), 1998, pp. 204-209
ENHANCED EFFECTS OF ADRIAMYCIN BY COMBINATION WITH A NEW RIBONUCLEOTIDE REDUCTASE INHIBITOR, TRIMIDOX, IN MURINE LEUKEMIA
Authors: FRITZERSZEKERES M NOVOTNY L ROMANOVA D GOBL R SEDLAK J VACHALKOVA A RAUKO P ELFORD HL SZEKERES T
Citation: M. Fritzerszekeres et al., ENHANCED EFFECTS OF ADRIAMYCIN BY COMBINATION WITH A NEW RIBONUCLEOTIDE REDUCTASE INHIBITOR, TRIMIDOX, IN MURINE LEUKEMIA, Life sciences (1973), 63(7), 1998, pp. 545-552
LOW-DOSE ASPIRIN DOES NOT LOWER IN-VIVO PLATELET ACTIVATION IN HEALTHY SMOKERS
Authors: PERNERSTORFER T STOHLAWETZ P STUMMVOLL G KAPIOTIS S SZEKERES T EICHLER HG JILMA B
Citation: T. Pernerstorfer et al., LOW-DOSE ASPIRIN DOES NOT LOWER IN-VIVO PLATELET ACTIVATION IN HEALTHY SMOKERS, British Journal of Haematology, 102(5), 1998, pp. 1229-1231
ARE ALLERGIC REACTIONS TO SKIN CLIPS ASSOCIATED WITH DELAYED WOUND-HEALING
Authors: LHOTKA CG SZEKERES T FRITZERSZEKERES M SCHWARZ G STEFFAN I MASCHKE M DUBSKY G KREMSER M ZWEYMULLER K
Citation: Cg. Lhotka et al., ARE ALLERGIC REACTIONS TO SKIN CLIPS ASSOCIATED WITH DELAYED WOUND-HEALING, The American journal of surgery, 176(4), 1998, pp. 320-323
SIMULTANEOUS DETERMINATION OF THE NEW ANTICANCER AGENT AMIDOX AND ITSMETABOLITES IN RAT BILE AND PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: VIELNASCHER E ROMANOVA D NOVOTNY L SZEKERES T ELFORT HL THALHAMMER T JAGER W
Citation: E. Vielnascher et al., SIMULTANEOUS DETERMINATION OF THE NEW ANTICANCER AGENT AMIDOX AND ITSMETABOLITES IN RAT BILE AND PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 696(2), 1997, pp. 267-274
THE ENZYME RIBONUCLEOTIDE REDUCTASE - TARGET FOR ANTITUMOR AND ANTI-HIV THERAPY
Authors: SZEKERES T FRITZERSZEKERES M ELFORD HL
Citation: T. Szekeres et al., THE ENZYME RIBONUCLEOTIDE REDUCTASE - TARGET FOR ANTITUMOR AND ANTI-HIV THERAPY, Critical reviews in clinical laboratory sciences, 34(6), 1997, pp. 503-528
ACTIVE CELL-DEATH IN OVARIAN-CARCINOMA CELLS CAN BE INDUCED WITH BENZAMIDE RIBOSIDE, AN INHIBITOR OF THE GUANOSINE PATHWAY
Authors: GRUSCH,"FUHRMANN G SZEKERES T FINDENIG G KROHN K JAYARAM HN KRUPITZA G
Citation: G. Grusch,"fuhrmann et al., ACTIVE CELL-DEATH IN OVARIAN-CARCINOMA CELLS CAN BE INDUCED WITH BENZAMIDE RIBOSIDE, AN INHIBITOR OF THE GUANOSINE PATHWAY, European journal of cancer, 33, 1997, pp. 80-80
THE NEW INHIBITORS OF RIBONUCLEOTIDE REDUCTASE - COMPARISON OF SOME PHYSICOCHEMICAL PROPERTIES
Authors: ROMANOVA D VACHALKOVA A SZEKERES T ELFORD HL NOVOTNY L
Citation: D. Romanova et al., THE NEW INHIBITORS OF RIBONUCLEOTIDE REDUCTASE - COMPARISON OF SOME PHYSICOCHEMICAL PROPERTIES, Journal of pharmaceutical and biomedical analysis, 15(7), 1997, pp. 951-956
DNA-PROTECTIVE ACTIVITY OF NEW RIBONUCLEOTIDE REDUCTASE INHIBITORS
Authors: RAUKO P ROMANOVA D MIADOKOVA E MACAKOVA K NOVOTNY L ELFORD HL SZEKERES T
Citation: P. Rauko et al., DNA-PROTECTIVE ACTIVITY OF NEW RIBONUCLEOTIDE REDUCTASE INHIBITORS, Anticancer research, 17(5A), 1997, pp. 3437-3440
IRON-BINDING-CAPACITY OF DIDOX (3,4-DIHYDROXYBENZOBYDROXAMIC ACID) AND AMIDOX (3,4-DIHYDROXYBENZAMIDOXIME) NEW INHIBITORS OF THE ENZYME RIBONUCLEOTIDE REDUCTASE
Authors: FRITZERSZEKERES M NOVOTNY L VACHALKOVA A FINDENIG G ELFORD HL SZEKERES T
Citation: M. Fritzerszekeres et al., IRON-BINDING-CAPACITY OF DIDOX (3,4-DIHYDROXYBENZOBYDROXAMIC ACID) AND AMIDOX (3,4-DIHYDROXYBENZAMIDOXIME) NEW INHIBITORS OF THE ENZYME RIBONUCLEOTIDE REDUCTASE, Life sciences, 61(22), 1997, pp. 2231-2237
MODULATION OF 5-FLUOROURACIL RESISTANCE IN HUMAN COLON-TUMOR CELL-LINES BY AZIDOTHYMIDINE
Authors: FINDENIG G MADER RM FRITZERSZEKERES M STEGER GG JAEGER W SZEKERES T
Citation: G. Findenig et al., MODULATION OF 5-FLUOROURACIL RESISTANCE IN HUMAN COLON-TUMOR CELL-LINES BY AZIDOTHYMIDINE, Oncology research, 8(5), 1996, pp. 189-196
A NEW MODE OF TREATMENT OF HUMAN PAPILLOMA-VIRUS ASSOCIATED ANOGENITAL LESIONS USING A NONSTEROID ESTROGEN ANALOG
Authors: SCHON HJ GRGURIN M SZEKERES T SCHURZ B
Citation: Hj. Schon et al., A NEW MODE OF TREATMENT OF HUMAN PAPILLOMA-VIRUS ASSOCIATED ANOGENITAL LESIONS USING A NONSTEROID ESTROGEN ANALOG, Wiener Klinische Wochenschrift, 108(2), 1996, pp. 45-47
GENES RELATED TO GROWTH AND INVASIVENESS ARE REPRESSED BY SODIUM-BUTYRATE IN OVARIAN-CARCINOMA CELLS
Authors: KRUPITZA G GRILL S HARANT H HULLA W SZEKERES T HUBER H DITTRICH C
Citation: G. Krupitza et al., GENES RELATED TO GROWTH AND INVASIVENESS ARE REPRESSED BY SODIUM-BUTYRATE IN OVARIAN-CARCINOMA CELLS, British Journal of Cancer, 73(4), 1996, pp. 433-438
CYTOTOXIC EFFECTS OF A DOXORUBICIN-TRANSFERRIN CONJUGATE IN MULTIDRUG-RESISTANT KB CELLS
Authors: FRITZER M SZEKERES T SZUTS V JARAYAM HN GOLDENBERG H
Citation: M. Fritzer et al., CYTOTOXIC EFFECTS OF A DOXORUBICIN-TRANSFERRIN CONJUGATE IN MULTIDRUG-RESISTANT KB CELLS, Biochemical pharmacology, 51(4), 1996, pp. 489-493
AN AUTOCRINE FACTOR OF AN OVARIAN-CARCINOMA CELL-LINE INDUCES C-MYC TRANSCRIPTS, DNA-SYNTHESIS AND APOPTOSIS
Authors: KRUPITZA G HARANT H DITTRICH E HUBER H SZEKERES T DITTRICH C
Citation: G. Krupitza et al., AN AUTOCRINE FACTOR OF AN OVARIAN-CARCINOMA CELL-LINE INDUCES C-MYC TRANSCRIPTS, DNA-SYNTHESIS AND APOPTOSIS, European journal of cancer, 31A, 1995, pp. 40-40
IRON-BINDING-CAPACITY OF TRIMIDOX (3,4,5-TRIHYDROXYBENZAMIDOXIME), A NEW INHIBITOR OF THE ENZYME RIBONUCLEOTIDE REDUCTASE
Authors: SZEKERES T VIELNASCHER E NOVOTNY L VACHALKOVA A FRITZER M FINDENIG G GOBL R ELFORD HL GOLDENBERG H
Citation: T. Szekeres et al., IRON-BINDING-CAPACITY OF TRIMIDOX (3,4,5-TRIHYDROXYBENZAMIDOXIME), A NEW INHIBITOR OF THE ENZYME RIBONUCLEOTIDE REDUCTASE, European journal of clinical chemistry and clinical biochemistry, 33(11), 1995, pp. 785-789
SODIUM-BUTYRATE INHIBITS C-MYC SPLICING AND INTERFERES WITH SIGNAL-TRANSDUCTION IN OVARIAN-CARCINOMA CELLS
Authors: KRUPITZA G HARANT H DITTRICH E SZEKERES T HUBER H DITTRICH C
Citation: G. Krupitza et al., SODIUM-BUTYRATE INHIBITS C-MYC SPLICING AND INTERFERES WITH SIGNAL-TRANSDUCTION IN OVARIAN-CARCINOMA CELLS, Carcinogenesis, 16(5), 1995, pp. 1199-1205
RIBONUCLEOTIDE REDUCTASE AS TARGET FOR EN ZYME-DIRECTED CHEMOTHERAPY-EFFECTS OF TRIMIDOX (3,4,5-TRIHYDROXYBENZOHYDROXIME), A NEW INHIBITOR OF RIBONUCLEOTIDE REDUCTASE
Authors: FINDENIG G VIELNASCHER E GOBL R FRITZERSZEKERES M SZEKERES T
Citation: G. Findenig et al., RIBONUCLEOTIDE REDUCTASE AS TARGET FOR EN ZYME-DIRECTED CHEMOTHERAPY-EFFECTS OF TRIMIDOX (3,4,5-TRIHYDROXYBENZOHYDROXIME), A NEW INHIBITOR OF RIBONUCLEOTIDE REDUCTASE, Wiener Klinische Wochenschrift, 107(22), 1995, pp. 694-697
GROWTH PROMOTION BY HOMOCYSTEINE THIOLACTONE AND ITS ALPHA-ALKYLATED DERIVATIVE - A ROLE FOR EXCESS GROWTH IN HOMOCYSTINURIAS
Authors: LUBEC B SZEKERES T
Citation: B. Lubec et T. Szekeres, GROWTH PROMOTION BY HOMOCYSTEINE THIOLACTONE AND ITS ALPHA-ALKYLATED DERIVATIVE - A ROLE FOR EXCESS GROWTH IN HOMOCYSTINURIAS, Amino acids, 7(1), 1994, pp. 109-112
BIOCHEMICAL AND ANTITUMOR-ACTIVITY OF TRIMIDOX, A NEW INHIBITOR OF RIBONUCLEOTIDE REDUCTASE
Authors: SZEKERES T GHAREHBAGHI K FRITZER M WOODY M SRIVASTAVA A VANTRIET B JAYARAM HN ELFORD HL
Citation: T. Szekeres et al., BIOCHEMICAL AND ANTITUMOR-ACTIVITY OF TRIMIDOX, A NEW INHIBITOR OF RIBONUCLEOTIDE REDUCTASE, Cancer chemotherapy and pharmacology, 34(1), 1994, pp. 63-66
SYNERGISTIC CYTOTOXIC EFFECTS OF CHEMOTHE RAPEUTIC DRUGS ON COLON-TUMOR CELLS BY SIMULTANEOUS INHIBITION OF DE-NOVO AND SALVAGE METABOLIC PATHWAYS
Authors: SZEKERES T FRITZER M SCHON HJ FINDENIG G LHOTKA C
Citation: T. Szekeres et al., SYNERGISTIC CYTOTOXIC EFFECTS OF CHEMOTHE RAPEUTIC DRUGS ON COLON-TUMOR CELLS BY SIMULTANEOUS INHIBITION OF DE-NOVO AND SALVAGE METABOLIC PATHWAYS, Wiener Klinische Wochenschrift, 106(14), 1994, pp. 459-463
SYNERGISTIC GROWTH-INHIBITORY AND DIFFERENTIATING EFFECTS OF TRIMIDOXAND TIAZOFURIN IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS
Authors: SZEKERES T FRITZER M STROBL H GHAREHBAGHI K FINDENIG G ELFORD HL LHOTKA C SCHOEN HJ JAYARAM HN
Citation: T. Szekeres et al., SYNERGISTIC GROWTH-INHIBITORY AND DIFFERENTIATING EFFECTS OF TRIMIDOXAND TIAZOFURIN IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS, Blood, 84(12), 1994, pp. 4316-4321
COMPARISON OF BIOCHEMICAL PARAMETERS OF BENZAMIDE RIBOSIDE, A NEW INHIBITOR OF IMP DEHYDROGENASE, WITH TIAZOFURIN AND SELENAZOFURIN
Authors: GHAREHBAGHI K SREENATH A HAO Z PAULL KD SZEKERES T COONEY DA KROHN K JAYARAM HN
Citation: K. Gharehbaghi et al., COMPARISON OF BIOCHEMICAL PARAMETERS OF BENZAMIDE RIBOSIDE, A NEW INHIBITOR OF IMP DEHYDROGENASE, WITH TIAZOFURIN AND SELENAZOFURIN, Biochemical pharmacology, 48(7), 1994, pp. 1413-1419
CYTOTOXICITY, DIFFERENTIATING ACTIVITY AND METABOLISM OF TIAZOFURIN IN HUMAN NEUROBLASTOMA-CELLS
Authors: PILLWEIN K SCHUCHTER K RESSMANN G GHAREHBAGHI K KNOFLACH A CERMAK B JAYARAM HN SZALAY SM SZEKERES T CHIBA P
Citation: K. Pillwein et al., CYTOTOXICITY, DIFFERENTIATING ACTIVITY AND METABOLISM OF TIAZOFURIN IN HUMAN NEUROBLASTOMA-CELLS, International journal of cancer, 55(1), 1993, pp. 92-95
Risultati: 1-25 | 26-28